These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6127125)

  • 1. [Correlation between the experimental and clinical effectiveness of benzodiazepines and their affinity for benzodiazepine receptors].
    Rudenko GM; Voronina TA; Shatrova NG; Chepelev VM
    Biull Eksp Biol Med; 1982 Aug; 94(8):54-6. PubMed ID: 6127125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychophysiologic characteristics of the individual psychotropic activity of benzodiazepine derivatives under experimental conditions].
    Val'dman AV; Kozlovskaia MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(6):911-9. PubMed ID: 27927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacology of uxepam].
    Zakusov VV; Voronina TA; Garibova TL; Pálosi E; Sporni L
    Farmakol Toksikol; 1983; 46(6):5-9. PubMed ID: 6140185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the GABA-transaminase activity in various structures of the rat brain after administration of benzodiazepine tranquilizers].
    Galust'ian GE; Ignatov IuD
    Biull Eksp Biol Med; 1983 Jan; 95(1):56-8. PubMed ID: 6131706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of tranquilizers of the 1,4-benzodiazepine series on the xanthine oxidase activity of the rat brain].
    Korotkina RN; Papin AA; Voronina TA; Karelin AA
    Biull Eksp Biol Med; 1988 Nov; 106(11):565-8. PubMed ID: 2904285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological profile of chlordesmethyldiazepam and other benzodiazepines.
    Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B; Lewandowska A; Przegaliński E
    Pol J Pharmacol Pharm; 1986; 38(2):207-13. PubMed ID: 2875452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the action of tranquilizers on reinforcement systems].
    Marusov IV
    Farmakol Toksikol; 1979; 42(3):203-8. PubMed ID: 36295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological and toxicological aspects of benzodiazepine compounds (author's transl)].
    Kapp W
    Anasth Intensivther Notfallmed; 1981 Jun; 16(3):125-7. PubMed ID: 6114678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of benzodiazepine tranquilizers on the development of toxic brain edema].
    Iasnetsov VS; Novikov VE
    Farmakol Toksikol; 1982; 45(2):106-8. PubMed ID: 6122593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence for GABA-ergic mechanisms in the action of benzodiazepines.
    Zakusov VV; Ostrovskaya RU; Kozhechkin SN; Markovich VV; Molodavkin GM; Voronina TA
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):313-26. PubMed ID: 23084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors.
    Mombereau C; Kaupmann K; van der Putten H; Cryan JF
    Eur J Pharmacol; 2004 Aug; 497(1):119-20. PubMed ID: 15321743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present status of benzodiazepines in psychopharmacology.
    Iversen LL
    Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the anticonvulsant effects of fenazepam].
    Voronina TA; Garibova TL; Nerobkova LN
    Farmakol Toksikol; 1980; 43(5):546-51. PubMed ID: 6108867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety].
    Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Shevchenko SL; Chernikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of diazepam and phenazepam on Leao's depression in brain edema].
    Vishnevskiĭ SE; Iasnetsov VS
    Farmakol Toksikol; 1983; 46(6):12-4. PubMed ID: 6140184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New evidence for a GABA-ergic component in the mechanism of action of benzodiazepine tranquilizers].
    Zakusov VV; Ostrovskaia RU
    Biull Eksp Biol Med; 1981 May; 91(5):571-4. PubMed ID: 6789910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.
    Dixon CI; Rosahl TW; Stephens DN
    Pharmacol Biochem Behav; 2008 Jul; 90(1):1-8. PubMed ID: 18313124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of psychophysiologic indices for the prognosis of the clinical action of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI; Marshak OV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):90-8. PubMed ID: 2907706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress in development of psychotropic drugs (1)--Anti-anxiety drugs].
    Kudo Y; Kudo T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):75-86. PubMed ID: 7796324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of benzodiazepine derivatives on human blood cholinesterase in vitro.
    Holmes JH; Kanfer I; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):367-70. PubMed ID: 29327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.